Trending now:  
EuroPCR 2026: SMART Trial Shows Hemodynamic Edge for Self-Expanding TAVI Valves at Three Years

Content for healthcare professionals only

Podcast |

04 Jun 2024
GDMT for HF
GDMT for HF
Cardiology Update
Loading
/

The DanGer Shock trial assessed the efficacy of the Impella CP ventricular assist device in reducing mortality following myocardial infarction (MI). In this episode, Dr. Chadi Alraies discusses this important trial with the principal investigator, Professor Jacob Møller.

For more cardiology research news join our newsletter or follow us on TwitterFacebookLinkedIn or Instagram.

Share:

Related Topics